93M1 Stock Overview
MPH Health Care AG, an investment company, engages in the healthcare business in Germany.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
MPH Health Care AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €20.60 |
| 52 Week High | €25.50 |
| 52 Week Low | €13.65 |
| Beta | 1.05 |
| 1 Month Change | -0.48% |
| 3 Month Change | 24.85% |
| 1 Year Change | 36.42% |
| 3 Year Change | -26.69% |
| 5 Year Change | -50.72% |
| Change since IPO | -11.29% |
Recent News & Updates
Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)
Sep 15
A Look At The Fair Value Of MPH Health Care AG (FRA:93M1)
Sep 02Recent updates
Shareholder Returns
| 93M1 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 5.6% | 3.9% | 2.0% |
| 1Y | 36.4% | -28.2% | 2.0% |
Return vs Industry: 93M1 exceeded the German Pharmaceuticals industry which returned -28.6% over the past year.
Return vs Market: 93M1 exceeded the German Market which returned 1.3% over the past year.
Price Volatility
| 93M1 volatility | |
|---|---|
| 93M1 Average Weekly Movement | 8.0% |
| Pharmaceuticals Industry Average Movement | 6.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 93M1 has not had significant price volatility in the past 3 months.
Volatility Over Time: 93M1's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1 | Patrick Brenske | www.mph-ag.de |
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology.
MPH Health Care AG Fundamentals Summary
| 93M1 fundamental statistics | |
|---|---|
| Market cap | €90.77m |
| Earnings (TTM) | €49.70m |
| Revenue (TTM) | €30.72m |
1.8x
P/E Ratio2.9x
P/S RatioIs 93M1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 93M1 income statement (TTM) | |
|---|---|
| Revenue | €30.72m |
| Cost of Revenue | €0 |
| Gross Profit | €30.72m |
| Other Expenses | -€18.98m |
| Earnings | €49.70m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 11.61 |
| Gross Margin | 100.00% |
| Net Profit Margin | 161.80% |
| Debt/Equity Ratio | 1.5% |
How did 93M1 perform over the long term?
See historical performance and comparison